Skip to main content
. 2012 Jul 10;74(2):370–375. doi: 10.1111/j.1365-2125.2012.04191.x

Table 3.

Crude and adjusted odds ratios (RR) of CDAD associated with NSAID exposure in the 90 days prior to the index date

NSAIDS exposure in the 90 days prior to the index date Cases Controls Crude Adjusted*
RR RR 95% CI
Any traditional NSAID 462 (34.0) 3 709 (28.4) 1.27 0.97 0.86, 1.10
Diclofenac 96 (7.1) 547 (4.2) 1.63 1.35 1.10, 1.67
Ibuprofen 42 (3.1) 446 (3.4) 0.91 0.85 0.62, 1.15
Naproxen 12 (0.88) 108 (0.83) 1.06 0.99 0.56, 1.75
Other traditional NSAIDs 38 (2.8) 262 (2.0) 1.36 1.10 0.79, 1.51
Cox-2 inhibitors 11 (0.81) 116 (0.89) 0.92 0.77 0.42, 1.39
Acetylsalicylic acid 319 (23.5) 2 656 (20.3) 1.18 0.88 0.77, 1.01
*

Adjusted for gender, comorbidities, prescription of antibiotics, H2-receptor antagonists, proton pump inhibitors and oral steroids.